News and Trends 20 Sep 2022
Positive results from Arecor Therapeutics’ clinical trial of rapid, concentrated insulin
Arecor Therapeutics today (September 20) announced positive results from a phase 1 clinical trial of its rapid, concentrated insulin product. The company’s candidate named AT278 is formulated using its Arestat…